These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23123533)

  • 1. New biomarkers in rheumatoid arthritis.
    Willemze A; Toes RE; Huizinga TW; Trouw LA
    Neth J Med; 2012 Nov; 70(9):392-9. PubMed ID: 23123533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACPA (anti-citrullinated protein antibodies) and rheumatoid arthritis.
    Toes RE; van der Woude D
    Acta Reumatol Port; 2011; 36(3):205-7. PubMed ID: 22113596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmunity in rheumatoid arthritis: different antigens--common principles.
    Trouw LA; Huizinga TW; Toes RE
    Ann Rheum Dis; 2013 Apr; 72 Suppl 2():ii132-6. PubMed ID: 23253931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis.
    Szodoray P; Szabó Z; Kapitány A; Gyetvai A; Lakos G; Szántó S; Szücs G; Szekanecz Z
    Autoimmun Rev; 2010 Jan; 9(3):140-3. PubMed ID: 19427413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage.
    Shi J; Knevel R; Suwannalai P; van der Linden MP; Janssen GM; van Veelen PA; Levarht NE; van der Helm-van Mil AH; Cerami A; Huizinga TW; Toes RE; Trouw LA
    Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17372-7. PubMed ID: 21987802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis.
    Shi J; van de Stadt LA; Levarht EW; Huizinga TW; Toes RE; Trouw LA; van Schaardenburg D
    Arthritis Rheum; 2013 Apr; 65(4):911-5. PubMed ID: 23279976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation and autoantibody markers identify rheumatoid arthritis patients with enhanced clinical benefit following rituximab treatment.
    Lal P; Su Z; Holweg CT; Silverman GJ; Schwartzman S; Kelman A; Read S; Spaniolo G; Monroe JG; Behrens TW; Townsend MJ
    Arthritis Rheum; 2011 Dec; 63(12):3681-91. PubMed ID: 22127691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Citrullinated peptide and its relevance to rheumatoid arthritis: an update.
    Luban S; Li ZG
    Int J Rheum Dis; 2010 Oct; 13(4):284-7. PubMed ID: 21199462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies.
    de Vries-Bouwstra JK; Goekoop-Ruiterman YP; Verpoort KN; Schreuder GM; Ewals JA; Terwiel JP; Ronday HK; Kerstens PJ; Toes RE; de Vries RR; Breedveld FC; Dijkmans BA; Huizinga TW; Allaart CF
    Arthritis Rheum; 2008 May; 58(5):1293-8. PubMed ID: 18438829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into the genetics of immune responses in rheumatoid arthritis.
    Ruyssen-Witrand A; Constantin A; Cambon-Thomsen A; Thomsen M
    Tissue Antigens; 2012 Aug; 80(2):105-18. PubMed ID: 22835281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential response of the rheumatoid factor and anticitrullinated protein antibodies during adalimumab treatment in patients with rheumatoid arthritis.
    Bos WH; Bartelds GM; Wolbink GJ; de Koning MH; van de Stadt RJ; van Schaardenburg D; Dijkmans BA; Nurmohamed MT
    J Rheumatol; 2008 Oct; 35(10):1972-7. PubMed ID: 18785316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Early diagnosis of rheumatoid arthritis with a test based upon a specific antigen: cyclic citrullinated peptide].
    van Venrooij WJ; van de Putte LB
    Ned Tijdschr Geneeskd; 2003 Feb; 147(5):191-4. PubMed ID: 12645351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.
    Schellekens GA; Visser H; de Jong BA; van den Hoogen FH; Hazes JM; Breedveld FC; van Venrooij WJ
    Arthritis Rheum; 2000 Jan; 43(1):155-63. PubMed ID: 10643712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-cyclic citrullinated antibodies: complementary to IgM rheumatoid factor in the early diagnosis of rheumatoid arthritis.
    Solanki K; Spellerberg M; Chapman P; Moller P; O'Donnell J
    N Z Med J; 2004 Oct; 117(1203):U1097. PubMed ID: 15477921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A new marker for the diagnosis of rheumatoid arthritis: cyclic citrullinated peptide antibodies (anti-CCP)].
    Altindiş M
    Mikrobiyol Bul; 2003 Oct; 37(4):313-8. PubMed ID: 14748270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-CCP Antibody, a Marker for the Early Detection of Rheumatoid Arthritis.
    van Venrooij WJ; van Beers JJ; Pruijn GJ
    Ann N Y Acad Sci; 2008 Nov; 1143():268-85. PubMed ID: 19076355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-CarP antibodies as promising marker to measure joint damage and disease activity in patients with rheumatoid arthritis.
    Yee A; Webb T; Seaman A; Infantino M; Meacci F; Manfredi M; Benucci M; Lakos G; Favalli E; Schioppo T; Meroni PL; Mahler M
    Immunol Res; 2015 Feb; 61(1-2):24-30. PubMed ID: 25391608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of high-throughput autoantibody profiling for the discovery of novel antigenic targets in rheumatoid arthritis.
    Somers K; Stinissen P; Somers V
    Ann N Y Acad Sci; 2009 Sep; 1173():92-102. PubMed ID: 19758137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptidyl-arginine deiminase: an additional marker of rheumatoid arthritis.
    Basu PS; Majhi R; Ghosal S; Batabyal SK
    Clin Lab; 2011; 57(11-12):1021-5. PubMed ID: 22239037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.